Walking reduces recurrence of low back pain, study finds

FHS
June 20, 2024
2:09 pm

Adults with a history of low back pain went nearly twice as long without a recurrence of their back pain if they walked regularly, a world-first study has found.

AstraZeneca, Daiichi Sankyo withdraw application for lung cancer therapy

Datopotamab deruxtecan is intended for use in adults with locally advanced or metastatic nonsquamous NSCLC. Credit: New Africa/Shutterstock. AstraZeneca and Daiichi Sankyo have withdrawn their

December 26, 2024

Innovative TB risk scoring tool enhances patient care and workflow

Caitlin Dugdale, MD, MSc, and Kimon Zachary, MD, physicians in the Division of Infectious Diseases at Massachusetts General Hospital (MGH) and assistant professors of Medicine

January 29, 2025

AI drug firm Recursion moves from survival to industry domination

SALT LAKE CITY — On paper, Recursion Pharmaceuticals shouldn’t have worked. The company — or, at least, what existed at its founding in 2013 — hoped

August 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.